Detalhe da pesquisa
1.
Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey.
BMC Psychiatry
; 23(1): 464, 2023 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365543
2.
Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study.
BMC Psychiatry
; 23(1): 938, 2023 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38093196
3.
Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data.
BMC Psychiatry
; 22(1): 152, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232411
4.
Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis.
BMC Health Serv Res
; 21(1): 778, 2021 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34362353
5.
Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
J Sex Med
; 12(10): 2036-48, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26331383
6.
Characterizing Longitudinal Patterns in Cognition, Mood, And Activity in Depression With 6-Week High-Frequency Wearable Assessment: Observational Study.
JMIR Ment Health
; 11: e46895, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819909
7.
Mental health diagnoses and services utilization vary by wage level.
Am J Manag Care
; 29(4): 173-178, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104831
8.
User-Centered Design of a Digitally Enabled Care Pathway in a Large Health System: Qualitative Interview Study.
JMIR Hum Factors
; 10: e42768, 2023 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494099
9.
Longitudinal study to assess antidepressant treatment patterns and outcomes in individuals with depression in the general population.
J Affect Disord
; 321: 272-278, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280197
10.
Design and Implementation of a Digitally Enabled Care Pathway to Improve Management of Depression in a Large Health Care System: Protocol for the Implementation of a Patient Care Platform.
JMIR Res Protoc
; 12: e43788, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351941
11.
Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study.
Front Psychiatry
; 13: 977560, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683990
12.
Characterizing primary care for patients with major depressive disorder using electronic health records of a US-based healthcare provider.
J Affect Disord
; 300: 377-384, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953925
13.
An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study.
JMIR Ment Health
; 9(10): e33871, 2022 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301615
14.
Adherence and persistence among patients with major depressive disorder enrolled in the vortioxetine tAccess Patient Support Program.
Curr Med Res Opin
; 37(8): 1385-1392, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33904815
15.
A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.
Psychopharmacology (Berl)
; 233(21-22): 3787-3795, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27572830
16.
The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.
J Psychopharmacol
; 30(3): 242-52, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864543
17.
Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
Int Clin Psychopharmacol
; 30(5): 255-64, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26020712